Company: BNBX
Filing Date: 2025-10-30
Form Type: S-1
Source: 0001104659-25-103871
Chunk: 121

Company: BNB PLUS CORP.
Filing Date: 2025-10-30
Form: S-1
Chunk 121
---
 no family relationships between any directors or executive officers. The following table identifies and sets forth certain biographical and other information regarding our executive officers and directors, including their ages as of September 30, 2025.

| Name                         |   | Age |   | Position                              |
| Clay Shorrock                | ​ |  42 | ​ | Chief Executive Officer and President |
| Beth M. Jantzen              | ​ |  48 | ​ | Chief Financial Officer               |
| Judith Murrah                | ​ |  66 | ​ | Chairperson of the Board              |
| Yacov A. Shamash             | ​ |  74 | ​ | Director                              |
| Robert B. Catell             | ​ |  87 | ​ | Director                              |
| Joseph D. Ceccoli            | ​ |  61 | ​ | Director                              |
| Elizabeth M. Schmalz Shaheen | ​ |  73 | ​ | Director                              |

Executive Officers Clay Shorrockhas served as our Chief Executive Officer and President since September 2025 and our Chief Legal Officer and Executive Director of Business Development since April 2021, and as the President of LineaRx since December 2024. In his previous roles with the Company, Mr. Shorrock led the Company’s legal, regulatory, risk mitigation, intellectual property and business development functions and was instrumental in the development of the Company’s LineaDNA and LineaIVT platforms. Mr. Shorrock previously served as general and intellectual property counsel to the Company from November 2016 through April 2019. Prior to rejoining the Company in April 2021, Mr. Shorrock was a member of the intellectual property groups of Florida-based Lowndes, Drosdick, Doster, Kantor & Reed, P.A. from February 2020 until April 2021 and Allen, Dyer, Doppelt & Gilchrist, P.A. from May 2019 until January 2020. Earlier in his career Mr. Shorrock was an associate at several New Jersey-based law firms where he focused on intellectual property and complex commercial transactions. Mr. Shorrock holds a B.A. in Biology from Franklin and Marshall College and a J.D. with a concentration in intellectual property from Seton Hall University Law School. Beth Jantzenhas been our Chief Financial Officer since February 15, 2015. Ms. Jantzen held the position of Controller from May